Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736086 · ClinicalTrials.gov registry record
RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System
A clinical trial of Cardiovascular Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 165
- Enrollment target
- 11
- Study locations
NCT00736086 is a study of Cardiovascular Disease and Peripheral Vascular Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 165 participants, below the 2,712-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (94% lower). The trial reports 11 study locations across 10 states.
The verdict
NCT00736086, a study of Cardiovascular Disease and Peripheral Vascular Disease, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
- 11
- Study locations
Study Summary
To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.
Conditions Studied
Interventions
- DEVICE Vessel Closure (StarClose™)
Study Locations (11)
New York
- New York Methodist Hospital - Brooklyn
- Buffalo Heart group - Buffalo
California
- Scripps Memorial Hospital - La Jolla
Georgia
- Fuqua Heart Center/ Piedmont Hospital - Atlanta
Illinois
- Heart Care Midwest (OSF/St Francis) - Peoria
Indiana
- The Care Group LLC (St. Vincent's Hospital) - Indianapolis
Michigan
- Bay Regional Medical Center - Bay City
Minnesota
- Minneapolis Heart Institute Foundation/Abbott Northwestern Hospital - Minneapolis
Missouri
- St. Luke's Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00736086
The ClinicalTrials.gov registry entry for NCT00736086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,712-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (94% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Vessel Closure (StarClose™) is the first listed.
NCT00736086 reports 11 study locations spanning 10 distinct geographic areas - top geographies include New York, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT00736086 about?
NCT00736086 is a clinical study titled "RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System". To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.
What is the current status of trial NCT00736086?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2006-03. Estimated completion is 2006-12.
What conditions does trial NCT00736086 study?
This clinical trial studies the following conditions: Cardiovascular Disease, Peripheral Vascular Disease.
What interventions are being tested in trial NCT00736086?
The interventions under investigation include: Vessel Closure (StarClose™) (DEVICE).
Who is sponsoring clinical trial NCT00736086?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00736086 being conducted?
This trial has 11 study locations across California, Georgia, Illinois, Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
WISE CVD - Continuation (WISE HFpEF)
RECRUITING
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RECRUITING · Phase 3
-
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
RECRUITING
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.